GSKNEUTRAL

GSK Return on Equity (ROE) Analysis

33.4%

Updated 300h ago·SEC filings & market data

Key Takeaway

Return on Equity (ROE) measures how much profit a company generates from each dollar of shareholder equity — at 33.4%, GSK produces 33.4 cents of profit for every dollar of equity.

Sector Performance

84th percentile

GSK

33.4%

Sector Median

13.3%

Sector Avg

17.0%

Prior Period

40.9%(Jun 2026)

↓ Declining

📊

Deep Analysis

Return on Equity (ROE) measures how much profit a company generates from each dollar of shareholder equity — at 33.4%, GSK produces 33.4 cents of profit for every dollar of equity.

This is well above the sector median of 13.4%, placing GSK in the 84th percentile among sector peers. The trend is unavailable: both the year-over-year change and quarter-over-quarter change are reported as N/A, so no directional movement can be assessed. The high ROE suggests efficient use of equity, but the absence of trend data leaves the durability of this performance unverified. That combination presents an opportunity from current profitability alongside uncertainty about whether it will persist. The metric supports the overall NEUTRAL verdict: the strong level is positive, yet the lack of trend offers no reason to upgrade the stock's outlook.

Frequently Asked Questions

What does the Return on Equity (ROE) tell investors about GSK?

ROE measures how effectively management turns equity into profit. Consistently above 15% is typically considered strong. Negative equity distorts this metric.

How is the Return on Equity (ROE) calculated?

Return on Equity (ROE) is calculated as: Net Income / Shareholders' Equity.

Who are GSK's closest peers by Return on Equity (ROE)?

The closest peers by Return on Equity (ROE) include: EVGO (-34.6%), MAR (-69.0%), BMBL (-76.9%), WBA (-82.7%), NIO (-84.0%).

📚

Learn More About Return on Equity (ROE)

What Is Return on Equity (ROE) and Is Higher Always Better?

Return on equity ROE measures how efficiently a company generates profit from shareholder capital. Learn how to decompose ROE using DuPont analysis and why high leverage can make it dangerous—with Apple and JPMorgan examples.

The Formula

Net Income / Shareholders' Equity

Why It Matters

ROE measures how effectively management turns equity into profit. Consistently above 15% is typically considered strong. Negative equity distorts this metric.